Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Abattis Bioceuticals Corp ATTBF

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic Cannabis
Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.


GREY:ATTBF - Post by User

Abattis Bioceuticals Corp
Bullboard Posts
User Avatar Image
(1)
•••
Comment by bumperstumperon Feb 04, 2019 8:52am
173 Views
Post# 29313640

RE:Halted

RE:HaltedJesus can this company do anything right??  

When a company fails to make timely disclosure of material information, the provincial securities regulators can issue a Cease Trade Order (CTO) which stops the trading of the company’s stock. Once issued, a CTO remains in effect until the company meets its disclosure obligations.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities